Applying the Evidence in CLL/SLL: Best Practices for Individualizing Therapy Selection

Gain a deeper understanding of therapies for chronic lymphocytic leukemia/small lymphocytic leukemia and how to incorporate evidence-based first-line therapies and sequencing strategies for relapsed/refractory disease through an expert-written ClinicalThought commentary, on-demand webcast, and accompanying downloadable resource and slides.

Share

Program Content

Activities

CLL VHA
Applying the Evidence in CLL/SLL: Best Practices for Individualizing Therapy Selection
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: April 28, 2025

Expires: October 27, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by educational grants from Lilly and Merck Sharp & Dohme LLC.

Lilly

Merck Sharp & Dohme, LLC